Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use-Reference-Cited by-同舟云学术

Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use

Published:2024-06-20 Issue:7 Volume:17 Page:
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Mirioglu Safak¹²^ORCID,Hocaoglu Rabia Hacer¹,Velioglu Arzu³^ORCID,Ozluk Yasemin⁴^ORCID,Dirim Ahmet Burak¹,Oruc Aysegul⁵^ORCID,Oto Ozgur Akin¹^ORCID,Yazici Halil¹,Caliskan Yasar¹⁶^ORCID

Affiliation:

1. Division of Nephrology, Istanbul University Istanbul Faculty of Medicine , Istanbul , Turkey

2. Department of Immunology, Istanbul University Aziz Sancar Institute of Experimental Medicine , Istanbul , Turkey

3. Division of Nephrology, Marmara University School of Medicine , Istanbul , Turkey

4. Department of Pathology, Istanbul University Istanbul Faculty of Medicine , Istanbul , Turkey

5. Division of Nephrology, Bursa Uludag University Faculty of Medicine , Bursa , Turkey

6. Center for Abdominal Transplantation, Saint Louis University School of Medicine , St Louis, MO , USA

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ckj/advance-article-pdf/doi/10.1093/ckj/sfae190/58290978/sfae190.pdf

Reference7 articles.

1. Kidney transplantation in C3 glomerulopathy: a case series;Regunathan-Shenk;Am J Kidney Dis,2019

2. Treatment of C3 glomerulopathy in adult kidney transplant recipients: a systematic review;Gonzalez Suarez;Med Sci (Basel),2020

3. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation;Zand;J Am Soc Nephrol,2014

4. Poor allograft outcome in Indian patients with post-transplant C3 glomerulopathy;Kumar;Clin Kidney J,2021

5. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy;Bomback;Kidney Int,2018